摘要: The combination of anticancer drugs with hyperthermia was only recently introduced as an experimental clinical strategy. This approach within the field medical oncology is based on convincing evidence that enhances therapeutic effect several chemotherapeutic agents, even in drug-resistant cells. Such a combined modality particular interest means overcoming limited efficacy conventional agents case large, resistant human tumors.